ABVX
Abivax SA American Depositary Shares
NASDAQ: ABVX · HEALTHCARE · BIOTECHNOLOGY
$106.24
-3.30% today
Updated 2026-04-29
Market cap
$8.42B
P/E ratio
—
P/S ratio
1,843.30x
EPS (TTM)
$-5.66
Dividend yield
—
52W range
$6 – $149
Volume
1.0M
Abivax SA American Depositary Shares (ABVX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $38.46M | $37.97M | $76.27M | $60.60M | $53.81M | $54.05M | $51.73M | $71.30M | $109.23M | $75.54M | $327.06M | $205.23M |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $5.60M | $5.64M | $43.15M | $27.84M | $20.88M | $20.98M | $18.24M | $37.67M | $75.21M | $36.18M | $285.97M | $170.67M |
| Total liabilities | $4.44M | $4.03M | $4.50M | $3.88M | $5.63M | $19.39M | $33.14M | $53.40M | $83.30M | $68.36M | $131.05M | $164.64M |
| Current liabilities | $2.12M | $1.89M | $3.72M | $3.55M | $5.44M | $8.49M | $12.39M | $19.41M | $32.26M | $51.46M | $88.11M | $92.83M |
| Long-term debt | — | — | — | — | — | — | $20.74M | $28.45M | $53.45M | $36.58M | $44.70M | $52.16M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | — | $-5.09M | $-21.05M | $-35.35M | $-46.58M | $-62.40M | $-93.03M | $-37.55M | $-81.81M | $-143.51M | $-282.95M | $-438.88M |
| Accounts receivable | $2.25M | $2.39M | $3.91M | $4.80M | $3.65M | $7.77M | $6.98M | $8.04M | $8.34M | $8.32M | $19.10M | $15.66M |
| Inventory | — | — | $117000.00 | $52000.00 | $199000.00 | — | $1.15M | $1.12M | $4.00M | $12.19M | $-5.88M | — |
| Goodwill | $32.75M | $32.01M | $32.01M | $32.01M | $32.01M | $32.01M | $32.01M | $32.01M | $32.74M | $18.42M | $18.42M | $18.42M |